Personalized cancer screening for patients with chronic kidney disease
Tailored Screening for Urinary System Cancers in Patients with Chronic Kidney Disease
This study is looking at the best ways to check for kidney and bladder cancer in people with chronic kidney disease, to help catch these cancers early and improve care for those at higher risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11290529 on NIH RePORTER |
What this research studies
This research focuses on developing tailored screening strategies for urinary system cancers in patients suffering from chronic kidney disease (CKD). Given the increased risk of cancers such as kidney and bladder cancer in CKD patients, the study aims to evaluate the effectiveness of different screening methods. A multidisciplinary team will analyze the health status of CKD patients to create guidelines that balance the benefits and risks of cancer screening. The goal is to improve early detection and management of cancers in this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 50 and older who have been diagnosed with chronic kidney disease.
Not a fit: Patients without chronic kidney disease or those who are not at risk for urinary system cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer screening protocols that enhance early detection and treatment for patients with chronic kidney disease.
How similar studies have performed: Previous research has indicated that tailored screening approaches can significantly improve cancer detection rates in high-risk populations, suggesting potential success for this study.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Kang, Stella — Columbia University Health Sciences
- Study coordinator: Kang, Stella
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.